Decoding pooled RNAi screens by means of barcode tiling arrays by Boettcher, Michael et al.
METHODOLOGY ARTICLE Open Access
Decoding pooled RNAi screens by means of
barcode tiling arrays
Michael Boettcher
1*, Johannes Fredebohm
1, Amin Moghaddas Gholami
1, Yafit Hachmo
2, Iris Dotan
2, Dan Canaani
2,
Jörg D Hoheisel
1
Abstract
Background: RNAi screens via pooled short hairpin RNAs (shRNAs) have recently become a powerful tool for the
identification of essential genes in mammalian cells. In the past years, several pooled large-scale shRNA screens
have identified a variety of genes involved in cancer cell proliferation. All of those studies employed microarray
analysis, utilizing either the shRNA’s half hairpin sequence or an additional shRNA-associated 60 nt barcode
sequence as a molecular tag. Here we describe a novel method to decode pooled RNAi screens, namely barcode
tiling array analysis, and demonstrate how this approach can be used to precisely quantify the abundance of
individual shRNAs from a pool.
Results: We synthesized DNA microarrays with six overlapping 25 nt long tiling probes complementary to each
unique 60 nt molecular barcode sequence associated with every shRNA expression construct. By analyzing dilution
series of expression constructs we show how our approach allows quantification of shRNA abundance from a pool
and how it clearly outperforms the commonly used analysis via the shRNA’s half hairpin sequences. We further
demonstrate how barcode tiling arrays can be used to predict anti-proliferative effects of individual shRNAs from
pooled negative selection screens. Out of a pool of 305 shRNAs, we identified 28 candidate shRNAs to fully or
partially impair the viability of the breast carcinoma cell line MDA-MB-231. Individual validation of a subset of
eleven shRNA expression constructs with potential inhibitory, as well as non-inhibitory, effects on the cell line
proliferation provides further evidence for the accuracy of the barcode tiling approach.
Conclusions: In summary, we present an improved method for the rapid, quantitative and statistically robust
analysis of pooled RNAi screens. Our experimental approach, coupled with commercially available lentiviral vector
shRNA libraries, has the potential to greatly facilitate the discovery of putative targets for cancer therapy as well as
sensitizers of drug toxicity.
Background
Breast cancer is caused by genetic and epigenetic altera-
tions of the genome, resulting in changes in expression
levels of certain genes [1]. In the past two decades, exten-
sive efforts have been undertaken to characterize genes
involved in breast cancer development. Genomic altera-
tions and gene expression signatures associated with
breast cancer and chemotherapy response have been
identified [2-4]. However, genes that are neither mutated
nor changed in their levels of expression may also play
crucial roles in the progression of breast cancer. One way
to identify such essential genes is the inhibition of their
expression via RNA interference (RNAi) followed by the
analysis of the resulting ‘loss-of-function’ phenotype.
RNAi screens are commonly used to analyze gene func-
tion in a variety of model organisms, the most popular
ones being C. elegans and Drosophila [5,6]. More
recently, shRNA libraries targeting the human and
mouse genome have become available [7,8]. These
libraries allow RNAi mediated ‘loss-of-function’ screens
in mammalian cell lines. Pooled RNAi screens have been
performed by several groups and revealed a number of
cancer cell essential genes [9-11]. The decoding of such
pooled RNAi screens by means of microarray analysis
has been described previously [12,13]. While some
groups employed probe sequences complementary to
each shRNAs’ specific 21 nt half-hairpin stem sequence
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lyze pooled shRNA screens [7,9,12]. These 60 nt barcode
sequences were cloned adjacent to each shRNA template,
allowing the determination of the abundance of indivi-
dual shRNA templates from a complex pool [7]. Up until
now analysis of pooled RNAi screens via barcode
sequences was performed by probes complementary to
the full length barcode. Here, we introduce the concept
of barcode tiling in order to analyze pooled shRNA
screens. We synthesized six partially overlapping probe
sequences, each 25 nucleotides long, complementary to
every unique 60 nucleotide barcode from the pool (Figure
1). This means that the abundance of each shRNA tem-
plate can be detected from a pool, via hybridization to six
different probe sequences rather than just one.
In a series of initial calibration experiments we
demonstrate how the barcode tiling approach can quan-
tify the abundance of individual template molecules
from a pool of 305 shRNA expression constructs. We
further directly compare this new approach of analyzing
pooled RNAi screens to the commonly performed analy-
sis via half hairpin probes. We provide evidence that the
analysis using barcode tiling probes is not only more
sensitive, but also dramatically increases the fraction of
analyzable shRNAs from a pool as compared to half
hairpin probe analysis.
To further assess the performance of the barcode til-
ing approach for the detection of essential genes in the
breast carcinoma cell line MDA-MB-231, a negative
selection screening system was established. We chose to
target anti-apoptotic genes which were previously shown
to be expressed in either breast carcinoma tissues or
normal human breast. From a pooled RNAi screen we
identified 28 different shRNA sequences which were
depleted from a pool of lentiviral infected cells over a
period of four weeks. Finally, eleven potentially inhibi-
tory as well as non-inhibitory shRNAs were selected for
individual analysis of their effects on the proliferation of
the cell line MDA-MB-231. Validation assays revealed
the genes BIRC5, BRCA1, HSPA8 and NUP62 to be
essential for the viability of the cell line.
The precise profiling of essential genes in cancer cell
lines together with their expression pattern, genomic
mutations and epigenetic status will lead to a more
refined picture of the mechanisms underlying cancer
development and the means of eradicating it.
Results
Half hairpin versus barcode tiling analysis
In order to assess sensitivity, reproducibility as well as
limitations of the barcode tiling approach, we prepared
four different template pools with engineered concentra-
tions of individual pGIPZ shRNA expression plasmids.
The exact composition of the four templates is summar-
ized in Table 1. In the reference pool a total of 305
expression plasmids were present in equimolar amounts.
In the test pools 1 - 3 only 245 constructs constituting
subpool-0 remained equimolar, while subpools-1 to -6,
consisting of ten constructs each, were diluted by the
factors indicated in Table 1. From each of the four
pools we separately PCR amplified half hairpin as well
as barcode sequences. The resulting PCR product pools
were purified, labeled and hybridized to individual DNA
microarrays. For both, half hairpin pools as well as bar-
code pools, exactly the same conditions were used for
purification, labeling and hybridization. In order to
equalize hybridization properties between barcode tiling
probes (25 nt) and half hairpin probes (21 nt), we addi-
tionally synthesized 25 nt half hairpin microarray
probes, containing 4 nt from the common vector con-
text. We found an approximate 2-fold median array sig-
nal intensity increase from 25 nt half hairpin probe
sequences as compared to 21 nt probes. Hence we
included only 25 nt half hairpin probes into further
analysis.
Histograms of signal intensities from the hybridized
half hairpin as well as the barcode reference pool are
shown in Figure 2A and 2B. Absolute signal intensities
are displayed as multiples of the reference arrays back-
ground signal intensity. We found 49% of the half hair-
pin probes and 82% of the barcode tiling probes to have
signal intensities above a threshold of 4-fold the median
Figure 1 shRNA expression construct. Expression of shRNAs from pGIPZ vector constructs is driven by an RNA Polymerase II promoter (CMV).
Each shRNA template is associated with a unique 60 nt barcode sequence. Every barcode sequence can be amplified by one primer pair from a
pool of constructs. For analysis of pooled RNAi screens, six overlapping tiling probe sequences (25 nt) complementary to each barcode were
synthesized on a Geniom One microarray. puro
r, puromycin resistance gene; shRNA, shRNA template; White areas indicate common sequence
among all shRNA expression constructs.
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only shRNA expression constructs represented by more
than two half hairpin probe replica or more than one
barcode tiling probe above the 4-fold threshold in the
reference array. Under these conditions we found that
44% of the constructs could be detected via half hairpin
probes whereas 92% were detectable by means of bar-
code tiling probes.
In order to determine the abundance of expression
constructs in test pools 1, 2 and 3 we normalized signal
intensities from each of the three test arrays to the cor-
responding signal intensities from the reference array.
The calculated (test/reference) signal intensity ratios
hence represent a measure for the relative abundance of
every shRNA expression construct in each test pool. In
a second step, all signal intensity ratios were normalized
to the ratios obtained from the equimolar subpool-0 of
each array and averaged for every dilution factor. Fig-
ures 2C and 2D summarize ratios from all three test
pools analyzed via half hairpin or barcode tiling probes
respectively. Table 2 further gives an overview of mean
ratios together with the corresponding standard devia-
tion, p-value and number of analyzable shRNA expres-
sion constructs for every dilution step.
Negative selection screen
In order to assess the performance of barcode tiling
arrays in negative selection screens, we established a
screening system to detect essential genes in the breast
carcinoma cell line MDA-MB-231. For that purpose,
lentiviruses carrying each of the 305 different shRNA
expression constructs, targeting 121 individual antiapop-
totic genes (see Additional file 1), were pooled. This len-
t i v i r a lm i xw a su s e dt oi n f e c tM D A - M B - 2 3 1b r e a s t
carcinoma cells at a low multiplicity of infection (MOI)
of 0.3, while selecting for puromycin. The low MOI
ensured most cells would carry a maximum of one
knock-down construct targeting a single gene. After five
days of puromycin selection, total high molecular weight
(HMW) DNA was extracted and served as a reference
pool (tzero). Another cell fraction was cultured for an
additional four weeks and then subjected to HMW
DNA extraction, representing the test pool (tend). The
barcode sequences from tzero and tend of the pooled
screen were recovered by means of PCR on HMW
genomic DNA, labeled and hybridized to two individual
barcode tiling arrays. To account for differences in viral
titers as well as in PCR amplification and hybridization
efficiencies of individual probe sequences, all probe sig-
nal intensities from the test pool (tend)w e r en o r m a l i z e d
to the reference pool from time point zero (tzero) by cal-
culating the (tend/tzero) ratio. Lower titers of individual
viruses in the viral pool for example would result in
lower tzero as well as tend signal intensities. If the titer of
a particular virus at time point zero was too low, the
corresponding tzero tiling probe signals would not
exceed the selected threshold and hence these shRNA
expression constructs would be excluded from further
analysis. By applying a threshold of 10-fold the median
background intensity for probe signals in the tzero refer-
e n c ea r r a yw ea v o i d e dt h ed e s c r i b e dp r o b l e m s .A d d i -
tionally, a high threshold is important for the tzero
reference pool in order to provide the dynamic range
necessary to quantify the abundance of shRNA expres-
sion constructs in the test pool tend.
Correspondence analysis of the negative selection
screens
Associations between tiling probes and barcode
sequences were analyzed by means of correspondence
analysis. Correspondence analysis aims to separate dis-
similar objects, in our case tiling probe sequences as
well as barcode sequences, from one another [14]. Thus,
similar objects are clustered together resulting in small
distances, whereas dissimilar objects are located further
a p a r t .Ap r o j e c t i o no ft h i sa n a l y s i si ss h o w ni nF i g u r e
3A where time point zero signal intensities from all 305
barcodes were used to determine the association
between each of the six different tiling probes represent-
ing every barcode, marked as colored squares. Expect-
edly, contiguous tiling probes, sharing the highest
similarity with one another, are located closer to each
other than tiling probes sharing no sequence similarity.
In a second step, all barcodes, represented as black
dots, were spaced in the projection according to their
association with each of their six tiling probes. Strongest
signal intensity from one particular tiling probe as com-
pared to the remaining five means strongest association
of the barcode with this tiling probe. For positive asso-
ciations of a barcode with a particular tiling probe, both
objects are located in the same direction from the cen-
troid. The larger the distance from the centroid, the
stronger the associations between the barcode and the
given tiling probe. For negative associations, each of the
two objects lies on opposite sides of the centroid. This
Table 1 Scheme of dilution series of pGIPZ shRNA
expression plasmids
Reference pool Test pool 1 Test pool 2 Test pool 3
Subpool-0 1 1 1 1
Subpool-1 1 9e-01 4e-01 2e-03
Subpool-2 1 1e-03 8e-01 3e-01
Subpool-3 1 1e-04 2e-01 7e-01
Subpool-4 1 1e-01 1e-05 6e-01
Subpool-5 1 5e-01 1e-02 1e-06
Subpool-6 1 4e-03 4e-02 2e-04
Rows show the dilution factors of each of the seven shRNA expression
construct subpools in each of the four template pools used for PCR
amplification via half hairpin primers or barcode primers respectively.
Subpool-0 consists of 245 different pGIPZ plasmids; while subpools-1 to -6
consist of ten different pGIPZ plasmids each.
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Page 3 of 16Figure 2 Comparison between half hairpin and barcode tiling analysis. Shown are the histograms of probe signal intensities from reference
arrays of half hairpin (A) and barcode tiling probes (B) as multiples of the median background intensity. Dashed lines represent a 4-fold median
background intensity threshold. Normalized (test/reference) ratios are plotted against the indicated dilution factors in linear (top) and logarithmic
scale (bottom) for analysis via half hairpin (C) and barcode tiling probes (D). Values for (test/reference) ratios, standard deviations, p-values and
number of analyzable constructs per dilution step are shown in Table 2.
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to their signal intensity profiles at time point zero. An
example of strong association is given by the barcode
sequences from constructs BIRC5-A and HSPA8-B,
highlighted in the projection. Both barcodes show a
positive association with tiling probe two and, at the
same time, a negative association with tiling probes
four, five and six. In other words, tzero signal intensities
detected from tiling probe two were much stronger for
both barcodes than signal intensities detected from tiling
probes four, five and six. Interestingly, no general pre-
ference for any of the tiling probes was detected, as
represented by the equal distribution of all vector pro-
files in the projection.
Identification of candidate essential genes
The depletion of a certain barcode over the time of the
screen is expected to result in a decreased (tend/tzero)
ratio and thus indicate that the associated shRNA tar-
geted a gene which was essential for the proliferation of
the cell line MDA-MB-231. Therefore, log2 signal inten-
sity ratios (tend/tzero) were calculated from all signals
that passed the described tzero filter criteria and averaged
for each tiling probe sequence individually. In total,
three independent replicate microarray experiments
were carried out, resulting in a maximum of nine signal
intensity ratios for each tiling probe. Tiling probes
represented by less than four out of the possible nine
replicate signal ratios were discarded. A summary of all
determined log2 ratios is shown in Additional file 2 and
raw microarray data is accessible through ArrayExpress
(Additional file 3). Figure 3B further gives an overview
of the fractions of barcodes that were detectable by the
indicated number of tiling probes. Expression constructs
represented by at least two barcode tiling probes were
considered for further analysis. Altogether, out of 305
shRNA expression constructs included in the pool, 278
(91%) could be analyzed by means of the described
criteria.
A heat map of all log2 ratios from Additional file 2 is
shown in Figure 3C. Lines represent the 278 shRNAs
sorted by the mean value of their corresponding log2
ratios from tiling probes retained after filtering. Table 3
further shows the correlation coefficients (r²) between
different tiling probes. As expected, correlation between
log2 ratios from contiguous tiling probes is highest (r² =
0.84, +/-0.02; Table 4) since they share the highest
sequence similarity. With a decrease in sequence simi-
larity, correlation also decreases. Thus, tiling probes
sharing no common sequence display the lowest correla-
tion (r² = 0.68, +/-0.02). A ranking of the mean log2
ratios, representing the abundance of each shRNA in
the pool after four weeks of screening, is shown in Fig-
ure 4A. Those log2 ratios were then plotted against their
significance. The volcano plot in Figure 4B gives an
overview of the results from our pooled screen. It shows
the distribution of log2 ratios determined for each
Table 2 Comparison of half hairpin and barcode tiling analysis
Half hairpin probes Barcode tiling probes
Dilution factor Mean ratio [test/ref.] s p-value n Dilution factor Mean ratio [test/ref.] s p-value n
1e-06 0.04 0.06 8e-28 7 1e-06 0.02 0.02 4e-80 10
1e-05 0.14 0.19 7e-28 6 1e-05 0.04 0.02 4e-77 9
1e-04 0.19 2 1e-04 0.04 0.01 5e-67 9
2e-04 0.05 0.09 8e-19 4 2e-04 0.02 0.01 3e-90 9
1e-03 0.37 0.18 1e-09 4 1e-03 0.04 0.03 5e-75 10
2e-03 0.03 0.04 5e-23 4 2e-03 0.02 0.01 4e-70 8
4e-03 0.11 0.08 7e-21 4 4e-03 0.06 0.04 7e-80 9
1e-02 0.16 0.12 6e-33 7 1e-02 0.07 0.01 8e-80 10
4e-02 0.31 0.09 2e-17 4 4e-02 0.20 0.05 7e-57 9
1e-01 0.58 0.15 7e-11 6 1e-01 0.31 0.09 9e-40 9
2e-01 0.85 2 2e-01 0.49 0.09 6e-21 9
3e-01 0.88 0.08 3e-01 4 3e-01 0.64 0.12 6e-17 10
4e-01 0.94 0.10 7e-01 4 4e-01 0.74 0.04 1e-09 8
5e-01 0.97 0.10 9e-01 7 5e-01 0.78 0.06 7e-08 10
6e-01 0.83 0.23 6e-02 6 6e-01 0.85 0.05 3e-04 9
7e-01 1.04 2 7e-01 0.88 0.09 9e-03 9
8e-01 0.97 0.08 1e+00 4 8e-01 0.96 0.09 5e-01 10
9e-01 1.14 0.38 9e-02 4 9e-01 1.01 0.09 8e-01 8
1e+00 1.00 0.18 1e+00 106 1e+00 1.00 0.12 1e+00 225
Shown are the normalized (test/reference) mean ratios together with the corresponding standard deviations (s), p-values and numbers of analyzable shRNA
expression constructs (n) for each dilution factor. The p-values reflect significance of the differences between mean ratios obtained from the undiluted subpool-0
and the indicated dilution factors. For n < 3, no standard deviation or p-value could be determined.
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Page 5 of 16shRNA, relative to their calculated p-values. We found
that 28 candidate constructs showed negative log2 ratios
together with a p-value < 0.05, indicating their depletion
from the pool.
Validation of candidate essential genes
To verify the potential anti-proliferative effects of candi-
dates identified through the analysis of the pooled RNAi
screen, we selected eleven shRNA expression constructs
for closer analysis in an arrayed 96-well format. First of
all, two shRNA expression constructs, termed BRCA1-A
A
B
C
Figure 3 Barcode tiling probe performance in negative selection RNAi screens. A - Colored squares represent the six tiling probes
complementary to each barcode sequence. Black spots represent signal intensity profiles at time point zero from each of the barcode
sequences included in the pooled screen. The intersection of the dashed lines marks the position of the centroid. Validated candidate constructs
are highlighted. B - Tiling probes with reference (tzero) signal intensities below a 10-fold median background intensity threshold were excluded
from analysis. Shown are percentages of 305 shRNA expression constructs included in the pooled screen that were detectable by the indicated
number of barcode tiling probe sequences above the 10-fold threshold. For 91 percent of the shRNA expression constructs more than one
barcode tiling probe matched those criteria (right of the dashed line). Only those barcodes were considered for further analysis. Percent values
represent absolute counts from Additional file 2 relative to the total number of 305 shRNA expression constructs. C - A heat map was generated
from log2 ratios obtained from each tiling probe (TP) that passed the filter criteria, corresponding to log2 values in Additional file 2. Columns
represent the six different tiling probes and lines the 278 barcode sequences retained after filtering sorted by their tiling probe mean log2
values. White cells represent tiling probes which did not pass the described filter criteria.
Table 3 Cross-correlation between tiling probes.
TP1 TP2 TP3 TP4 TP5 TP6 Tiling probe
0.86 0.70 0.68 0.67 0.67 TP1
0.84 0.78 0.72 0.70 TP2
0.86 0.74 0.68 TP3
0.84 0.75 TP4
0.81 TP5
TP6
Correlation coefficients (r²) between log2 ratios from all analyzed tiling probes
(TP) are shown.
Boettcher et al. BMC Genomics 2010, 11:7
http://www.biomedcentral.com/1471-2164/11/7
Page 6 of 16and BRCA1-B, both encoding identical shRNA sequences
targeting the expression of BRCA1, but associated with
two different 60 nt barcode sequences were selected for
validation. The log2 ratios from both constructs indicated
a significant anti-proliferative effect [(BRCA1-A (-1.706,
p = 1.3e-4)/BRCA1-B (-1.145, p = 1e-5)]. We transduced
the constructs individually into the host cell line and
examined their potential to reduce target mRNA abun-
dance, inhibit cell viability and induce apoptosis. For
BRCA1-A as well as for BRCA1-B we detected close to
Table 4 Impact of probe sequence similarity on
correlation.
Sequence similarity (nt) r
2 mean s
0 0.68 0.02
4 0.69 0.02
11 0.74 0.03
18 0.84 0.02
The mean r² values from all tiling probes sharing 18, 11, 4 nt or no sequence
similarity is shown. Correlation is strongest between probes with a sequence
overlap of 18 nt and decreases with reduced sequence similarity.
Figure 4 Overview of results from negative selection screens. A - The log2 (tend/tzero) signal intensity ratios were calculated from all probes
that passed the described filter criteria and averaged for each shRNA expression construct. Negative log2 ratios indicate the depletion of cells
expressing a particular shRNA from the pool of cells, following the four weeks of the screen. B - The log2 ratios determined for each shRNA
expression construct were plotted against their significance. The red dashed line represents a p-value of 0.05 which was used as cut off.
Highlighted in red are significant candidate shRNAs (numbers) and validated candidate constructs. The indicated numbers correspond to the
numbers given in the Additional file 2.
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Page 7 of 16Figure 5 Validation assays of individual candidate constructs. A - Shown are the (tend/tzero) ratios from the pooled screen, the target gene
expression relative to the NSC at six days post-infection, the cell viability relative to the NSC at eight days post-infection, and the activity of
caspase 3/7 relative to NSC as a measure of apoptosis induction at six days post infection. NSC, non silencing control. B - Shown are the (tend/
tzero) ratios determined over four weeks of the pooled screen, together with the cell viability relative to the NSC at eight and sixteen days post-
infection. The inhibition of HSPA8 leads to a more pronounced decrease in viability at sixteen days as compared to eight days post infection, in
accordance with the (tend/tzero) ratios. NSC, non silencing control.
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Page 8 of 16equal reduction of BRCA1 expression, a concomitant
decrease in cell viability and induction of caspases 3/7, a
hallmark of apoptosis (Figure 5A).
In much the same way as for BRCA1,f u r t h e rc o n -
structs targeting expression of the genes BIRC5 (BIRC5-
A-D), NUP62 (NUP62-A-B) and HSPA8 (HSPA8-A-C)
were analyzed. For each of the three genes we identified
at least one construct with a significant log2 ratio below
-0.5 and one construct showing a ratio greater than -0.5.
Expression levels were reduced below 0.4-fold that of the
non-silencing control (NSC) by at least one construct tar-
geting each of the three mentioned genes. Cells with effi-
cient reduction of BIRC5 and NUP62 expression were
strongly impaired in their viability when assayed eight
days post-infection (BIRC5-A-C/NUP62-A-B). In the
case of HSPA8, a reduction of mRNA expression to 0.1-
fold that of the NSC caused only a mild reduction in cell
viability (HSPA8-A). Moreover, transduction of BIRC5-
A-C as well as NUP62-A-B induced caspases 3/7 unlike
any of the HSPA8 targeting constructs (Figure 5A).
The weak inhibition of viability after reduction of
HSPA8 expression was unexpected considering the log2
ratios from HSPA8-A (-0.885, p = 2.0e-5) and HSPA8-B
(-0.446, p = 3.2e-2). A major discrepancy between both
assays, however, is their duration. While the pooled
screens were carried out over a period of four weeks,
validation assays were performed eight days post infec-
tion. To test for the possibility of HSPA8 knock-down
impairing viability later than eight days post infection,
we decided to perform another viability assay for the
constructs HSPA8-A-C at sixteen days post infection.
As shown in Figure 5B, inhibition of viability was
detected for HSPA8-A as well as for HSPA8-B, resem-
bling the (tend/tzero) ratios determined from the pooled
screen.
Discussion
Technical considerations
In this manuscript we demonstrate how our barcode til-
ing approach facilitates highly reproducible and quanti-
tative analysis of pooled RNAi screens. As compared to
previous approaches employing a single half-hairpin or
full length barcode probe [9-11,15,16], we used six non-
identical tiling probe sequences to measure the abun-
dance of shRNA expression constructs from three test
pools of pGIPZ plasmids with engineered concentra-
tions. We directly compared our approach to the analy-
sis of the same pools via half hairpin probe sequences.
When we apply a threshold of 4-fold the median back-
ground intensity to the reference array from the half
hairpin as well as the barcode tiling probes, we retain
49% of the half hairpin probes and as many as 82% of
the barcode tiling probes. These values are similar to
the findings from Silva et al. who determined 60% of the
half hairpin and 80% of the full barcode sequences to
exceed 4-fold background intensity [9]. One possible
reason for the reduced fraction of half hairpin as com-
pared to barcode reference signals passing the threshold
is the PCR reaction used to amplify the molecular tags.
Due to the complementary nature of shRNA sequences,
self-annealing could be an explanation for the reduced
signal intensity. Seeing as the forward primer binding
site in the loop sequence of the shRNA consists of only
19 nucleotides, a rather low annealing temperature of
50°C had to be used. The stem of the shRNA, however,
is 21 nt long. Hence, a sequence dependent, selective
self-annealing of specific shRNAs could result in ineffi-
cient PCR amplification of those half hairpin sequences
from a pool. As a consequence, the probe signal in the
reference pool will decrease below the 4-fold threshold
a n db ee x c l u d e df r o mf u r t h er analysis. Given that no
such self-complementary sequences are found in the
barcodes, a more equal amplification of individual
sequences from a pool is likely.
Further advantages arise from the size of the 60
nucleotide long barcode sequence. Tiling the sequence
into six 25 nt long probes allows the omission of regions
in the barcode with unfavorable hybridization properties.
Seeing as six dissimilar tiling probes represent each bar-
code, identical signal intensities from all six tiling probes
would be expected, if hybridization properties between
them were equal. As illustrated by the distribution of
vector profiles in Figure 3A, signal intensities obtained
from the six different tiling probes representing every
barcode vary dramatically, indicating very different
hybridization properties of different tiling probes. Apply-
ing a high 10-fold background threshold to the tzero
reference pool excluded tiling probes with weak signal
intensities from further analysis. As summarized in Fig-
ure 3B, for 57% of the cases, all six barcode tiling probes
passed the 10-fold background threshold. For another
34%, however, at least one tiling probe did not exceed
the threshold, resulting in only two to five analyzable til-
ing probes per barcode. In total we could analyze 91% of
shRNA expression constructs using more than one tiling
probe with a tzero signal above the 10-fold threshold
from the negative selection screens. Similarly, when
applying a 4-fold background threshold to the pGIPZ
plasmid reference pool, we detected 92% of the shRNA
expression constructs with more than one tiling probe.
This is a substantial increase compared to the 44% of
shRNA expression constructs analyzable via half hairpin
probe sequences.
Besides an enhanced fraction of analyzable shRNA
expression constructs, the detection by means of bar-
code tiling probes also increases the statistical robust-
ness of the analysis. Seeing as the abundance of each
shRNA expression construct is detected by at least two,
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Page 9 of 16in most cases even six different tiling probes, variations
resulting from probe sequence biases are minimized.
This is reflected by the lower standard deviations as well
as p-values when comparing barcode tiling with half
hairpin probe results (Table 2). Additionally, the correla-
tion coefficients presented in Table 4 clearly point out
the difference in log2 ratios obtained from different til-
ing probes of the same barcode. If probe sequence prop-
erties had no impact on the determined log2 ratios, the
correlation coefficient should not decrease with
decreased sequence similarity. However, we found corre-
lation between log2 ratios from probes sharing 18 out of
25 bp nucleotide sequence similarity to be r² = 0.84.
The correlation between tiling probe sequences
decreased further with reduced similarity (Table 4).
When detecting the abundance of shRNA expression
constructs via half hairpin probes on the other hand,
each (test/reference) ratio is determined based on one
single probe sequence. Consequently, the variance of
mean values determined from the pGIPZ plasmid dilu-
tion series is generally greater, when analyzing the pools
via half hairpin as compared to barcode tiling probes
(Table 2). Incorporating signals from different tiling
probes reduces sequence biases and allows more accu-
rate detection of the abundance of individual shRNA
expression constructs from a pool. Figure 2D further
illustrates how barcode tiling analysis yields highly
reproducible (test/reference) ratios that allow quantifica-
tion of the relative abundance of individual shRNA
expression constructs over a large data area, ranging
from 7e-1 to 1e-2. The first test dilution factor that can
be distinguished from the undiluted reference with high
significance (p < 1e-2) is 7e-1 (Table 2). Any test con-
centration below 1e-2 fold the reference concentration
resulted in a (test/reference) ratio below 0.07. This goes
to show that barcode tiling analysis can not only quan-
tify shRNA expression construct abundance over a large
data area, but also strongly reduces chances to detect
false positives as well as false negatives. In comparison,
half hairpin analysis allows quantification, if at all, only
in a more limited data area (1e-1 to 1e-2), together with
decreased reproducibility, making false positive as well
as negative detection more likely (Figure 2C).
In summary, comparing half hairpin with barcode til-
ing probe analysis of the same templates highlights the
differences between both analysis methods. A dramatic
increase in the fraction of analyzable constructs together
with much more statistically robust and accurate (test/
reference) ratios clearly demonstrates the advantages of
the barcode tiling approach over the customary half
hairpin analysis.
Negative selection screen
For a negative selection screen, the 305 pGIPZ plasmids
were packaged into lentiviral particles and a pool of
virus was used to infect the breast carcinoma cell line
MDA-MB-231. In an initial calibration step, we dis-
carded probe sequences displaying tzero signal intensities
that were below 10-fold background, as compared to a
4-fold background used for the analysis of the engi-
neered pGIPZ plasmid pools. This resulted in only nine
percent of the shRNA constructs from the pooled screen
which did not fulfill the criteria for further analysis (Fig-
ure 3B). Similarly, analysis of the equimolar pGIPZ
reference pool, which contained all 305 expression con-
structs, resulted in eight percent of the shRNA expres-
sion constructs not fulfilling the described criteria.
These finding indicate that we either had incorrect bar-
code sequence information (partly obtained from Open
Biosystems Inc.), resulting in non-complementary probe
sequences on the microarray, or problems with PCR
amplification of the barcodes represented by the unde-
tectable probe signals and that low titers of individual
viruses in the pool were not responsible for undetectable
shRNA expression constructs.
From 28 candidate shRNAs identified from the pooled
negative selection screen to potentially inhibit the viabi-
lity of the breast carcinoma cell line MDA-MB-231, a
subset was selected for arrayed validation assays. We
found that reduced BRCA1 expression resulted in cas-
pase 3/7 induction and decreased viability of the cells.
These findings are in accord with the essential role of
BRCA1 in embryonic cell proliferation [17]. Paradoxi-
cally, under non-physiological over-expression condi-
tions, BRCA1 induces apoptosis, and its silencing
increases viability of certain cancer cells [18,19]. Our
findings indicate that in MDA-MB-231, BRCA1 inhibi-
tion might be more detrimental than in other cell lines.
In this context it is also worth mentioning the potential
role of the BRCA1 binding partner BARD1 as an essen-
tial gene for MDA-MB-231 cell growth. From our DNA
microarray data analysis we found the log2 ratio for the
BARD1 targeting construct V2LHS_93186 to be as low
as -2.228 (p = 1.01e-6). Interestingly, BARD1 has been
described before as being essential for the function of
BRCA1 and the survival of embryonic mice [20]. Taken
together, our data suggests an important role for func-
tional BRCA1 pathways in MDA-MB-231 cell viability.
Besides the tumor suppressor BRCA1,w ei d e n t i f i e d
three more candidate genes whose expression was
demonstrated to be of importance for the proliferation
of the breast cancer cell line MDA-MB-231. Among
those genes was the inhibitor of apoptosis BIRC5,t h e
nuclear pore complex (NPC) component NUP62 and
the heat shock protein 70 family member HSPA8.
BIRC5 is known to be an Inhibitor of Apoptosis (IAP)
that is over expressed in numerous human cancers
including breast cancer [21]. It has been claimed that
BIRC5 has the potential to be a prognostic marker in
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effects on the proliferation of MDA-MB-231 after
siRNA mediated silencing of BIRC5 have been docu-
mented [23]. Here we confirm that inhibition of BIRC5
expression by shRNA below 0.2-fold of its endogenous
level strongly inhibits proliferation of MDA-MB-231
cells via caspase 3/7 activation. These findings provide
f u r t h e re v i d e n c ef o rt h ep o t entially essential role of
BIRC5 in human breast cancer.
The ubiquitously expressed NUP62 has been described
to be an essential part of the Nuclear Pore Complex. It
has been reported to be involved in cargo transport
across the nuclear envelope [24]. Importantly, recently a
role for NUP62 in cell cycle regulation has been pro-
p o s e d[ 2 5 ] .H e r ew ed e m o n s t r a t et h a tNUP62 knock-
down leads to induction of apoptosis, together with a
decrease in viability.
Finally, we identified the heat shock cognate protein
HSPA8 (Hsc70) to be important for the viability of
MDA-MB-231 cells. The highly conserved protein can
bind to nascent polypeptides and facilitate their correct
folding. It is ubiquitously expressed in the cytosol of a
variety of non-tumor as well as cancerous cells including
breast cancer [26]. It has also been described by Rohde
et al. (2005) that the knock-down of HSPA8 in HeLa
cells generated an elongated fibroblast-like morphology
before rounding up and detachment from the culture
dish. In concordance with those findings we observed a
very similar phenotype in MDA-MB-231 after efficient
HSPA8 knock-down at eight days post-infection (Figure
6A). However, viability was only slightly impaired at
that time point. Thus we decided to record another
time point at sixteen days post-infection. Indeed, we
could show a much more pronounced inhibition of via-
bility at sixteen days post infection with HSPA8-A and
HSPA8-B (Figure 5B), as predicted from their (tend/tzero)
signal intensity ratio. Additionally, MDA-MB-231 cells
infected with HSPA8-A also detached from the cell cul-
ture dish at sixteen days post infection, which is again
consistent with the findings from Rohde et al. (Figure
6B).
Taken together, our data illustrates how inhibiting
the expression of different essential genes can influ-
ence the proliferation of MDA-MB-231 at different
immediacy. While, for example, the log2 ratios deter-
mined via microarray analysis of pooled screens from
the constructs BIRC5-B (-0.948, p =1 . 5 e - 3 ) ,B I R C 5 - C
(-0.954, p = 3.2e-3) and HSPA8-A (-0.885, p =2 . 0 e - 5 )
are almost identical, their viability at eight days post
infection varies greatly (Figure 5A). Both constructs
targeting BIRC5 show similar reduction of cell viability
at eight days post infection (BIRC5-B = 0.62 +/-0.1
and BIRC5-C = 0.69 +/- 0.14), whereas the construct
HSPA8-A shows much weaker effects (0.86 +/-0.15).
The inhibitory effect of HSPA8-A only becomes
noticeable at sixteen days post infection (Figure 5B).
To further illustrate this issue, we plotted the viability
data against the (tend/tzero) ratios for the constructs we
used for validation assays (Figure 7). While the ratio
determined from the pooled screen represents a mea-
sure for proliferation over 33 days, the viability assay
only detects effects that occur within eight days post-
infection. If knock-down of HSPA8, BIRC5 and NUP62
induced inhibition of proliferation with the same
immediacy one would expect all data points to be on
one linear regression line. However, whereas depletion
of some genes takes no longer than eight days to
almost completely inhibit the viability of the infected
cells (e.g. NUP62-A), some others take a longer period
of time (e.g. BIRC5-A, HSPA8-A). These differences
are further reflected by the striking morphological
changes in cells eight days post infection with the con-
structs NUP62-A, BIRC5-A and HSPA8-A (Figure 6A).
Introduction of NUP62-A, for instance, resembles the
typical apoptosis phenotype of MDA-MB-231 leading
to small round cells that finally detach from the cell
culture dish. Introducing BIRC5-A, on the other hand,
results in cells much larger than the control cells
which are unable to divide but do not detach from the
surface until eight days post infection. HSPA8-A cells,
finally, seem to be only slightly impaired in their ability
to divide but display the fibroblast-like morphology
described for HeLa cells by Rohde et al (2005) before
detaching from the surface at sixteen days post infec-
tion (Figure 6B).
Conclusions
I nt h ew o r kp r e s e n t e d ,w ed e m o n s t r a t eh o wp o o l e d
RNAi screens can be quantitatively and reproducibly
analyzed by means of barcode tiling arrays. We clearly
show the advantages of this novel method over the com-
monly performed analysis via half hairpin arrays. To
further exploit the full potential of barcode tiling, opti-
mal tiling probe sequences need to be experimentally
determined for each barcode present in a given shRNA
expression library. This calibration step would ensure a
maximized fraction of analyzable expression constructs
combined with a reduced sequence bias as compared to
currently used approaches.
Besides essential gene discovery, a variety of additional
exciting applications for pooled RNAi screens become
conceivable with the help of increased sensitivity
obtained from barcode tiling analysis. One intriguing
idea, for example, are pooled synthetic lethality screens
[27,28] allowing the identification of cancer specific
molecular targets. Such screens require accurate meth-
ods for the detection of particular shRNA abundance.
Our work provides the methodological scaffolding to
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Page 11 of 16Figure 6 Microscopic images of altered cell morphology after efficient knock-down of the indicated genes. A - Cells at eight days post
infection with the indicated shRNA expression constructs. While in the case of NUP62-A we observed the typical apoptosis phenotype of MDA-
MB-231, in the cases of BIRC5-A and HSPA8-A the morphology was very different. BIRC5-knock-down cells were several times larger than cells
expressing the NSC, and HSPA8 knock-down cells displayed a fibroblast-like phenotype. NSC, non silencing control. Magnification is 10x. B -
Sixteen days post infection cells expressing HSPA8-A were strongly impaired in their viability (see Figure 5B).
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experiments.
Methods
Lentiviral pool production and pooled negative selection
screen
HEK 293T cells were seeded in 96 well microplates at 2
×1 0
4 cells per well and co-transfected with 100 ng of
each of 305 individual pGIPZ human shRNA encoding
lentiviral plasmids (Open Biosystems), 50 ng psPAX2
and 25 ng pMD2.G plasmids (kindly provided by Prof.
Trono), respectively. Viruses were harvested 48 h and
72 h post-transfection, pooled and stored at -80°C. The
viral titer of the pool was determined to be 6 × 10
4
units/ml. MDA-MB-231 cells were seeded in triplicate
at 7 × 10
5 cells per 150 cm² cell culture flasks in stan-
dard cell culture medium (DMEM, 10% FCS, 1% penicil-
lin/streptomycin 10,000 U). Twenty four hours post
seeding 30 ml culture medium containing 8 μg/ml poly-
brene was added to each of the triplicates mixed with
3.3 ml of the viral pool to achieve a multiplicity of infec-
tion (MOI) of 0.3. Twenty four hours post-infection the
viral supernatant was aspirated and replaced with cul-
ture medium containing 0.5 μg/ml puromycin. Seventy
two hours post puromycin selection infected cells were
seeded into 150 cm² flasks at 3.5 × 10
5 cells per flask.
The remaining cells were harvested from each of the
three biological replicates and stored in aliquots of 1.5 ×
10
6 cells per replicate at -80°C for HMW DNA purifica-
tion (tzero). The selected cells were cultured in 0.5 μg/ml
puromycin medium for 28 additional days after tzero.
2×1 0
5 cells were transferred into fresh 150 cm² cell
culture flasks when 80% confluent, representing approxi-
mately 600 copies of each barcode in each triplicate.
From every passage, pellets of 1.5 × 10
6 cells were har-
vested and stored at -80°C.
Barcode and half hairpin DNA amplification and labeling
From each of the triplicate cell pellets harvested at five
days (tzero)a n d3 3d a y s( t end) post-infection, HMW
DNA was extracted using the QIAamp DNA Micro Kit
(Qiagen) according to the manufacturer’s instructions.
On average total amounts of HMW DNA extracted
from 1.5 × 10
6 cells were around 3 μgf r o me a c ho ft h e
three biological replicates. The purified DNA was eluted
in AE buffer and adjusted to 50 ng/μl. Each unique 60
nucleotide barcode DNA sequence was PCR amplified
from 100 ng genomic DNA template for each biological
triplicate. Assuming a weight of 3 pg per genome, this
represents an average of 350 copies per barcode. Seeing
as microarray experiments were performed in indepen-
dent triplicates, including PCR amplification of the bar-
code sequences, each barcode was represented by an
Figure 7 Results from pooled screens compared to viability data from selected shRNA expression constructs. Shown is the correlation
between (tend/tzero) signal intensity ratios from pooled screens and cell viability assays. While the (tend/tzero) ratios represent inhibition of
proliferation over a period of four weeks, the viability values only cover eight days. Thus this plot displays differences in the immediacy by which
the knock-down of different genes leads to inhibition of proliferation. Constructs are the same as in Figure 5A.
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amplified via PCR reactions using 0.4 μM5 ’ primer BC-
For [5’- AACTGAATACCTTGCTATCTCTTTGA-3’]
and 0.4 μM3 ’ primer BC-Rev [5’-TCCAGAGGTT-
GATTGTTCCA-3’], 250 μM of each dNTP (Fermentas),
1x HotStart Buffer (Qiagen), 1x Q-Solution (Qiagen),
1.5 mM MgCl2, 2.5 units HotStart polymerase (Qiagen)
and in a total volume of 100 μl. Thermal cycler PCR
conditions were 95°C for 15 min followed by 42 cycles
of 95°C for 40 sec., 58°C for 2:00 min., 72°C for 1:30
min. and finally 72°C for 10 min. PCR amplification
from pGIPZ plasmid pool templates was essentially per-
formed in the same way as from genomic DNA, only
that the copy number was adjusted to 1,500 copies per
equimolar pGIPZ construct (6 pg/100 μlP C R ) .F o rh a l f
hairpin amplification we used the 5’ primer HH-For [5’-
TAGTGAAGCCACAGATGTA-3’]a n dt h e3 ’ primer
HH-Rev [5’-CTAAAGTAGCCCCTTGAATTC-3’]. In a
gradient PCR we determined the optimal annealing tem-
perature for the half hairpin primer pair to be 50°C.
PCR products were purified using QIAquick PCR Purifi-
cation Kit (Qiagen) eluted in H2O and adjusted to 50
ng/μl. 150 ng of the PCR product from each triplicate
were pooled and incubated together with 30 ng/μlr a n -
dom primer oligonucleotides (Invitrogen) in a total
volume of 28 μl at 99°C for 5 min. After the denatura-
tion step 1x reaction buffer (1 M Hepes pH 6.6, 250
mM Tris-HCl pH 8.0, 25 mM MgCl2, 50 mM 2-mercap-
toethanol), 2 mM of each dATP, dCTP, dGTP and 1.3
mM dTTP, (Fermentas) together with 0.7 mM biotiny-
lated-dUTP (Roche), 0.4 mg/ml BSA (Sigma) and 7.5
units Klenow fragment (New England Biolabs) was
added to a total volume of 40 μl. After incubation at 37°
C for 3 h and 75°C for 10 min, 4 μl of 3 M sodium acet-
ate (pH 5.6) and 100 μl ethanol were added and the
DNA was precipitated at -80°C for 2 h. After centrifuga-
tion at 18,320 × g for 20 min the supernatant was aspi-
rated, the pellet was dried and resuspended in 15 μl1 x
hybridization mix (100 mM 2-[N-morpholino]ethanesul-
fonic acid (MES), 0.9 M NaCl, 20 mM Na2EDTA, 0.01%
(v/v) Tween-20, 0.5% BSA 0.1 mg/ml herring sperm
DNA (Febit).
Microarray design and hybridization
We used the photo-controlled in-situ synthesis technol-
ogy Geniom One (Febit Biomed GmbH) for synthesis,
hybridization and detection of microarrays [29]. The
Geniom One microarray is divided into eight individu-
ally accessible subarrays allowing the analysis of eight
samples in parallel. Half hairpin probes were synthesized
in quadruplicates as 21 nt sequence as well as 25 nt
sequences containing additional 4 nt from the common
mir-30 sequence at their 3’ end. As for the barcode
sequences, probes the length of 25 nt were synthesized
complementary to each 60 nt barcode. Every barcode
was covered by six probes in seven nucleotide jumps.
Three replicates of each probe were synthesized in each
subarray, resulting in 18 probes representing one bar-
code. In total 5490 probes were synthesized to detect
barcodes associated with 305 different shRNA expres-
sing constructs. Additionally eleven half hairpin and 66
tiling probes that did not match any barcode sequence
were synthesized in triplicates as negative controls.
Before hybridization the biotinylated barcode fragments
in 1x hybridization mix were heated to 95°C for 3 min
then placed on ice for 1 min. The denatured targets
from tzero and tend were then applied to individual sub-
arrays of the Geniom One microarray and incubated at
45°C for 16 h. After washing routines according to the
Febit protocol, each subarray was incubated with 5 μg/
ml streptavidin phycoerythrin (Invitrogen) in 6x SSPE
(0.9 M NaCl, 60 mM NaH2PO4,p H7 . 4a n d6m M
Na2EDTA). Signal intensity detection was performed
using the inbuilt CCD camera of the system and local
backgrounds were subtracted by means of internal Gen-
iom One software routines.
Data analysis
Median background signal intensities were determined
from half hairpin or barcode tiling probe sequences
complementary to eleven shRNA expression constructs
that were absent in the analyzed pools. Thresholds from
multiples of those background intensities were applied
as described. Signal intensities from each probe after
local background subtraction were normalized to the
median signal intensity of each subarray. The mean sig-
nal intensity ratios for each half hairpin or tiling probe
were calculated from the remaining probes by dividing
the signals from probes of the test-subarray by their cor-
responding reference-subarray probe signals. Finally, the
mean ratio from all tiling probes representing one bar-
code was determined. The analysis of the negative selec-
tion screen was performed in three independent
replicates. Their mean values were calculated as a mea-
sure of relative barcode abundance and hence the anti-
proliferative effect of associated shRNAs. Candidates
with biologically significant signals were identified using
linear models in the limma package [30] for the signifi-
cance analysis of microarray data. Coefficients, moder-
ated t-statistics and corresponding p-values for testing
all possible contrasts were calculated using Empirical
Bayesian methods. We used appropriate design matrixes
for the linear model fitting. We then performed pair-
wise comparisons between time point zero and time
point end tiling probes by means of contrast matrix.
The p-values for the coefficients of interest were
adjusted for multiple testing by means of Benjamini and
Hochberg’s algorithm [31], which controls the expected
false discovery rate (FDR) below the specified value.
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MDA-MB-231 cells were seeded in six-well microplates
at 10
4 cells per well. After 24 h, 90 μl of lentiviral super-
natant (approx. 6000 units) in culture medium contain-
ing 8 μg/ml polybrene was added to the cells to achieve
a MOI < 1. Twenty four hours later the lentiviral med-
ium was aspired and replaced by culture medium con-
taining 0.5 μg/ml puromycin. At day six post-infection,
cell pellets were collected and total RNA was isolated
using the RNeasy Mini Kit (Qiagen). One microgram of
total RNA from each sample was used for first strand
cDNA synthesis by Superscript III (Invitrogen). The
QuantiTect SYBR Green PCR Kit (Qiagen) was used in
a 384 well format. From each sample 12 ng template
cDNA was used in a total volume of ten microliters.
The reactions were carried out in triplicates in a Light-
Cycler 480 (Roche). The endogenous controls ACTB,
B2M and TUBA3C were used for normalization.
Viability assay
MDA-MB-231 cells were seeded in 96 well microplates
at 300 cells per well. After 24 h, 15 μlo fl e n t i v i r a l
supernatant (approx. 1000 units) in culture medium
containing 8 μg/ml polybrene was added to the cells to
achieve a MOI > 1. Twenty four hours later the viral
medium was aspirated and replaced by culture medium
containing 0.5 μg/ml puromycin or culture medium
without puromycin, respectively. 72 h post-infection
puromycin selected and non-selected cells were assayed
by resazurine assay in triplicate measurements (tzero).
The fluorescence intensity ratio from puromycin
selected cells divided by the intensity from unselected
cells was used as quality control for efficacy of lentiviral
infection. Another triplicate was allowed to proliferate
in fresh puromycin culturing medium for another five
days before resazurine measurement (tend). The fluores-
cence intensity ratio [tend/tzero] served as a relative mea-
sure for the anti-proliferative effect of tested shRNA
constructs. All values were normalized to a non-silen-
cing control (NSC) as well as an empty-pGIPZ vector
control. For the viability assays at sixteen days post
infection total cells were transferred from a well of a 96
well plate to that of a six well plate at six days post
infection.
Caspase activation assay
MDA-MB-231 cells were seeded in 96 microwell plates
at 300 cells per well. After 24 h, 15 μlo fl e n t i v i r a l
supernatant (MOI >1) in culture medium containing 8
μg/ml polybrene was added to the cells. Twenty four
hours later the viral medium was aspirated and replaced
by standard cell culture medium. At three and six days
post-infection a Caspase-Glo 3/7 Assay (Promega) was
performed. Luminescence was detected in a Fluorostar
plate reader (Perkin Elmer) after one hour of incubation
at room temperature.
Additional file 1: Results from negative selection screen, Shown are the
clone IDs as well as stem sequences and target genes from all 305
shRNA expression constructs included in the screen.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-7-
S1.XLS]
Additional file 2: Results from negative selection screen, From the 278
constructs analyzable by the described conditions, (tend/tzero)l o g 2 ratios
are summarized from individual tiling probes as well as mean log2 ratios
and p-values for each shRNA expression construct.
Click here for file
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